Molecular Screening Strategy to Identify a Non-invasive Delivery Mechanism for the Treatment of Middle Ear Disorders

Frontiers in Medicine

Meghan Spriggs¹  Daniel Schaerer¹  Molly Cooper¹  Yuge Xu¹  Arwa Kurabi¹  Allen F. Ryan² 

[1] Department of Surgery/Otolaryngology, UCSD School of Medicine, San Diego, CA, United States;Department of Surgery/Otolaryngology, UCSD School of Medicine, San Diego, CA, United States;Department of Neurosciences, UCSD School of Medicine, San Diego, CA, United States;San Diego VA Healthcare System, San Diego, CA, United States;

关键词: phage display;    peptide library;    targeted therapy;    middle ear;    delivery;    tympanic membrane (TM);   

DOI  :  10.3389/fmed.2020.503819

来源: Frontiers

【 摘 要 】

Middle ear ailments include a broad range of pathological conditions. Otitis media is the leading middle ear disease of childhood, which incurs significant health care resources in developed countries and, in developing countries, causes significant mortality and morbidity. Recurrent and chronic infections of the middle ear lead to the prolonged presence of inflammatory factors and cellular infiltrates resulting in temporary hearing loss. However, long-term alteration of the middle ear space can pose the risk of permanent damage to the delicate ear structures and cause tissue remodeling. While the etiopathogenesis of middle ear diseases is multifactorial, targeting the biological mechanisms and molecular networks that drive disease development is critical. Yet, a pivotal step in realizing the potential of molecular therapies is the development of methods for local drug delivery, since systemic application risks side effects. Utilizing bacteriophage display in the rat, we discovered rare peptides that are able to transit the intact tympanic membrane from the external canal to the middle ear cavity by an active process. An in vitro assay demonstrated that transport occurs across the tympanic membranes of humans and that the peptides cross the membrane independent of phage. Transport of phage, which is ~900 nm in length, suggests that these peptides could non-invasively deliver drug packages or gene therapy vectors into the middle ear.

【 授权许可】

CC BY